Skip to main content
Alan Shuldiner, MD, Endocrinology, Baltimore, MD

AlanRShuldinerMD

Endocrinology • Baltimore, MD

Diabetes, Lipid Metabolism

Professor of Medicine, University MD School of Medicine

Join to view full profile

Dr. Shuldiner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shuldiner's full profile

Already have an account?

  • Office

    22 S Greene St
    Baltimore, MD 21201
    Phone+1 410-706-1623
    Fax+1 410-706-1622

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1990
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1984 - 1985
  • Harvard Medical School
    Harvard Medical SchoolClass of 1984

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1987 - 2025
  • PA State Medical License
    PA State Medical License 2005 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Vitamin D Inhibits Human Platelet Aggregation: Implications for Hypercoagulable State in Diabetes 
    Baltimore, MD - 6/15/2014

Press Mentions

  • University of Maryland Medicine Launches Precision Health Study to Create Biggest and Most Diverse Research Database in State
    University of Maryland Medicine Launches Precision Health Study to Create Biggest and Most Diverse Research Database in StateJune 21st, 2022
  • Dr. Bruce P.M. Hamilton, Retired Chief of Endocrinology at Veterans Administration Medical Center and Professor of Medicine, Dies
    Dr. Bruce P.M. Hamilton, Retired Chief of Endocrinology at Veterans Administration Medical Center and Professor of Medicine, DiesAugust 2nd, 2021
  • Whole Genome Sequencing Identifies High-Impact Variants in Well-Known Pharmacogenomic Genes
    Whole Genome Sequencing Identifies High-Impact Variants in Well-Known Pharmacogenomic GenesSeptember 14th, 2018
  • Join now to see all

Grant Support

  • Secondary Prevention Of Subcortical Stroke Prevention Genetic SubstudyNational Institute Of Neurological Disorders And Stroke2011–2012
  • Research BaseNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Mid-Atlantic Nutrition Obesity Research CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Administrative CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Pharmacogenomics Of Anti-Platlet Intervention-2 (Papi-2) StudyNational Heart, Lung, And Blood Institute2010–2011
  • The Thrifty Microbiome: The Role Of The Gut Microbiota In Obesity In The AmishNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
  • Clinical Nutrition Research Unit Of MarylandNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
  • Pharmacogenomics Of Anti-Platelet Agents For CVD PreventionNational Institute Of General Medical Sciences2007–2009
  • Genetics CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Pharmacogenomics Of CVD Risk ReductionNational Institute Of General Medical Sciences2005–2009
  • Clinical Research Career Development (RMI)National Center For Research Resources2005–2009
  • Genetics Of Diabetes In The AmishNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2009
  • Genome-Wide Search For CVD Gene-Environment InteractionsNational Heart, Lung, And Blood Institute2002–2008
  • Pharmacogenomics Of Anti-Platelet Agents For CVD PreventNational Institute Of General Medical Sciences2005–2006
  • Core--Genetics, Genomics, And Genetic EpidemiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Pharmacogenetics Of PRO 12ala Ppar-Gamma-2National Center For Research Resources2005–2006
  • Genome Wide Research For CVD Gene Environment InteractionNational Center For Research Resources2005
  • Genetics Of Diabetes And ObesityNational Center For Research Resources2004–2005
  • Longevity Genes In Founder PopulationsNational Institute On Aging2001–2005
  • Pharmacogenetics Of PPAR - GammaNational Center For Research Resources2004
  • Genetics Of Longevity In The AmishNational Center For Research Resources2004
  • Amish Family Osteoporosis StudyNational Center For Research Resources2004
  • Genetic And Clinical Manifestations Of DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • Genetics Of Osteoporosis In The AmishNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2004
  • MALDI-TOF MS For High Throughput SNP AnalysisNational Center For Research Resources2002
  • Pharmacogenetics Of Pro12ala PPAR Gamma 2 In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Genetics Of Type II Diabetes Mellitus And ObesityNational Center For Research Resources2000
  • B3 Receptor Gene Mutation In Diabetes Prone MinoritiesNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1998
  • B3 Receptor Gene Mutation In Diabetes Prone MinoritiesNational Institute Of Diabetes And Digestive And Kidney Diseases1996

Dr. Alan Shuldiner, Dr. Alan Shuldiner, MD, Dr. A Shuldiner, Dr. Alan R Shuldiner